JP Stock MarketDetailed Quotes

4886 ASKA Pharmaceutical Holdings

Watchlist
  • 2300
  • -24-1.03%
20min DelayMarket Closed May 1 15:30 JST
66.16BMarket Cap8.63P/E (Static)

ASKA Pharmaceutical Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ASKA Pharmaceutical Holdings FY2025 Estimates Date

Currency：JPYMay 12, 2025

Estimate YoY
Revenue
63.84B
+1.58%
EPS
183.77
-31.04%
Analyst Rating
Buy

Mar 4, 2025

ASKA Pharmaceutical Holdings Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 3, 20252025/Q317.555B / ----
Nov 5, 20242025/Q216.019B / 16.030B--
Aug 5, 20242025/Q116.352B / 16.420B--
May 10, 20242024/Q414.019B / 14.176B--
Feb 5, 20242024/Q317.176B / 17.430B--
DatePeriodRevenue/EstimateEarnings Call
Feb 3, 20252025/Q317.555B / ----
Nov 5, 20242025/Q216.019B / 16.030B--
Aug 5, 20242025/Q116.352B / 16.420B--
May 10, 20242024/Q414.019B / 14.176B--
Feb 5, 20242024/Q317.176B / 17.430B--

Unlock Free Earnings Estimates

ASKA Pharmaceutical Holdings Earnings Reports

  • ASKA Pharmaceutical Holdings: Extraordinary Report

    Feb 7 01:41 ET

  • ASKA Pharmaceutical Holdings: Supplementary material on financial results for the 3rd quarter of the fiscal year ending 2025/3

    Feb 3 01:30 ET

  • ASKA Pharmaceutical Holdings: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)

    Feb 3 01:30 ET

  • ASKA Pharmaceutical Holdings: Confirmation letter

    Nov 8, 2024 01:04 ET

    • Read more

    Market Insights

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    Metaplanet
    3350
    394
    Murata Manufacturing
    6981
    1930.5
    Mitsui O.S.K. Lines
    9104
    4563.0
    4
    Alt
    260A
    113
    5
    Mitsubishi UFJ Financial Group
    8306
    1782.0
    Log In for the Full List
    Unlock Now